论文部分内容阅读
实验设益肝康冲剂大、中、小剂量组、正常组、病理组、齐墩果酸（阳性对照）组。结果表明，益肝康冲剂。3个剂量组均能显著降低卜半乳糖胺急性肝损伤大鼠的丙氨酸转氨酶、天门冬氨酸转氨酶活性，疗效与齐墩果酸片无差异（P＞0．05）；肝组织病检表明中、小剂量组几乎与阳性组一致，说明益肝康冲剂具有良好地保护D-半乳糖胺致大鼠急性肝损伤的作用。
Experimental set up Yigan Kang granules in large, medium and small dose groups, normal group, pathological group, oleanolic acid (positive control) group. The results showed that Yigankang granules. All three dose groups could significantly reduce the activity of alanine aminotransferase and aspartate aminotransferase in rats with acute hepatic injury induced by galactosamine, and the efficacy was not different from that of oleanolic acid tablets (P>0.05); liver tissue disease Examination showed that the middle and small dose groups were almost identical to the positive group, indicating that Yigankang Granules had a good protection against acute liver injury induced by D-galactosamine in rats.